Related Experiment Video
Updated: Jul 31, 2026

Detection of Low Copy Number Integrated Viral DNA Formed by In Vitro Hepatitis B Infection
Published on: November 7, 2018
Effect of a hepatitis B vaccination program on the prevalence of hepatitis B virus infection
F J Mahoney1, B A Woodruff, J J Erben
1Epidemiology Section, National Center for Infectious Diseases, Centers for Disease Control, Atlanta, Georgia 30333.
Insights
Hepatitis B immunization programs significantly reduced hepatitis B virus (HBV) infection rates in children. Early childhood vaccination is crucial for preventing both acute and chronic HBV in endemic regions.
Area of Science:
- * Public Health
- * Virology
- * Immunization
Background:
- * Hepatitis B virus (HBV) infection is a significant global health concern, particularly in areas with high endemicity.
- * The implementation of newborn hepatitis B immunization programs aimed to control HBV transmission.
- * Assessing the long-term impact of these programs on childhood infection rates is essential.
Purpose of the Study:
- * To evaluate the serologic evidence of hepatitis B virus (HBV) infection in children in American Samoa.
- * To compare HBV infection rates before and after the introduction of a hepatitis B immunization program for newborns and young children.
- * To determine the effectiveness of hepatitis B vaccination in preventing acute and chronic HBV infection.
Main Methods:
- * Serologic surveys were conducted in April 1991 among 3- to 4-year-old children and 6- to 11-year-old children in American Samoa.
- * Data from 1991 were compared with baseline data from 1985, prior to the widespread implementation of the immunization program.
- * Prevalence ratios (PR) and 95% confidence limits (CL) were calculated to assess infection rates.
Main Results:
- * Children born after the immunization program (tested in 1991) showed significantly lower rates of HBV infection and chronic HBV infection compared to children tested in 1985.
- * For 3- to 4-year-olds, HBV infection prevalence was 5/40 in 1985 versus 2/93 in 1991 (PR = 5.8). Chronic HBV infection was 3/40 in 1985 versus 0/95 in 1991.
- * For 6- to 11-year-olds, HBV infection prevalence was 32/121 in 1985 versus 53/386 in 1991 (PR = 1.9). Chronic HBV infection was 8/121 in 1985 versus 7/386 in 1991.
Conclusions:
- * The hepatitis B vaccine, when incorporated into routine childhood vaccination schedules, is highly effective in preventing acute and chronic HBV infection.
- * The findings demonstrate a significant reduction in HBV infection rates in children following the implementation of the immunization program.
- * Routine childhood vaccination is a critical strategy for controlling HBV in highly endemic regions.
Abstract:
In April 1991, surveys for serologic evidence of hepatitis B virus (HBV) infection were conducted among 3- to 4-year-old children born after a hepatitis B immunization program of newborns began and among 6- to 11-year-old children targeted for early childhood vaccination in American Samoa. Compared with 3- to 4-year-olds tested in 1991, children tested at baseline in 1985 were more likely to have been infected with HBV (5/40 vs. 2/93; prevalence ratio [PR] = 5.8, 95% confidence limits [CL] = 1.2, 28.7) and to have chronic infection with HBV (3/40 vs. 0/95; PR = undefined, lower CL = 1.2). Compared with 6- to 11-year-olds tested in 1991, children in 1985 were more likely to have been infected with HBV (32/121 vs. 53/386; PR = 1.9, CL = 1.3, 2.8) and to have chronic infection with HBV (8/121 vs. 7/386; PR = 3.6, CL = 1.3, 9.8). The incorporation of hepatitis B vaccine into routine childhood vaccination schedules can prevent acute and chronic HBV infection in areas of high endemicity.
More Related Videos
11:34A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target
Published on: May 10, 2022
04:11Real-Time Polymerase Chain Reaction-Based Detection and Quantification of Hepatitis B Virus DNA
Published on: December 15, 2023
Related Concept Videos
Vaccinations
Hepatitis
Viral Hepatitis I: Introduction